Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
-
Mobilicom Launches SkyHopper MultiBand: Delivering Cybersecure, Expansive Wideband Coverage for Loitering Drones and Robotics
-
Panama Partner Issues Purchase Order for DFR-X Drone System as Wrap Expands Non-Lethal Response Capabilities in the Region
-
Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder
-
Quantum Leap Energy Appoints Nate Salpeter, Ph.D., a Key Opinion Leader in Fluid Dynamics and Energy Technology, as its Chief Technology Officer
-
Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer
-
Lands' End Announces Fourth Quarter and Fiscal 2025 Earnings Conference Call
-
Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences
-
CervoMed to Participate in Upcoming Investor Conferences
-
Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort
-
FinHarbor Completes Core Deployment of Hybrid Neobank Platform for Asterium in Uzbekistan
-
Gilat to Highlight Next‑Generation Satellite Connectivity Technologies at Satellite 2026 – “Expanding 5G to Space”
-
BitMart US Launches Full U.S. Operations With zerohash as Its Crypto & Stablecoin Infrastructure Partner
-
BitMart US Launches Full U.S. Operations With zerohash as Its Crypto & Stablecoin Infrastructure Partner
-
Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as "Project Atlas" Hits Major Milestone
-
Independent Peterson Health Technology Institute evaluation validates impact of Cylinder Health’s digestive care model
-
Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call
-
Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates
-
Vior Gold Corporation Announces District Scale Projects Acquisition
-
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
-
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results
-
Atavistik Bio Closes $40 Million Series B Extension for Advancement of its Pipeline Bringing Total Round Proceeds to $160 Million
-
Victoria’s Secret & Co. Reports 2025 Fourth Quarter and Full Year Results
-
Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer
-
HPQ Silicon Finalizes Increased Ownership in Novacium SAS
-
Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates
-
Argo Renews Agreement with the Town of Bradford West Gwillimbury
-
Savanna Provides Update on Qualifying Transaction
-
GH Research Reports Full Year 2025 Financial Results and Provides Business Update
-
Eclipse Foundation showcases open source innovation at embedded world 2026; Releases 2025 IoT and Embedded Survey Report
-
TDECU Named 2026 Gallup Exceptional Workplace Award Winner for Second Time
-
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
-
Zen Media Launches GEO GPT™ — The First GPT That Shows How AI Talks About Your Brand
-
Media Advisory -- SATURDAY: Thousands to Rally in Toronto for 48th Annual International Women’s Day March
-
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
-
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026
-
Copper Quest Completes AI-Driven Analysis at Kitimat & Identifies Large Concealed Conductive Target
-
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results
-
Xunlei Limited Schedules 2025 Unaudited Fourth Quarter and Fiscal Year Earnings Release on March 12, 2026
-
Xanadu Highlights Strong Engagement at 2026 Analyst Day
-
BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal
-
Plug Power to Ring the Nasdaq Stock Market Closing Bell on March 6, 2026
-
G-III Apparel Group Announces Date for Fourth Quarter and Full Year Fiscal 2026 Results
-
USA Rare Earth to Acquire Texas Mineral Resources Corporation
-
Brilliant Earth Releases Fifth Annual Mission Report, Celebrating Two Decades of Transforming the Jewelry Industry
-
An oat campus: Oatly invests $16 million in its Swedish production plant to support growing global demand
-
Capital Clean Energy Carriers Corp. Announces Fourth Quarter 2025 Financial Results
-
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
-
Verisk Reiterates its Growth Targets and Outlines Strategy for its Next Phase of Compounding Growth at 2026 Investor Day
-
Lantronix Advances Platform Scaling Strategy With MediaTek-Based Embedded Compute Expansion
